scholarly article | Q13442814 |
P50 | author | Marco Pagni | Q47097366 |
Leonardo Scapozza | Q58448519 | ||
P2093 | author name string | Thierry Soldati | |
Pierre Cosson | |||
Hubert Hilbi | |||
Nabil Hanna | |||
Sébastien Kicka | |||
Christopher Harrison | |||
Gianpaolo Chiriano | |||
Agata Kranjc | |||
Valentin Trofimov | |||
Hajer Ouertatani Sakouhi | |||
Jahn Nitschke | |||
P2860 | cites work | The ESCRT and autophagy machineries cooperate to repair ESX-1-dependent damage at the Mycobacterium-containing vacuole but have opposite impact on containing the infection | Q61453633 |
Molecular basis for the polyamine-ompF porin interactions: inhibitor and mutant studies | Q73590585 | ||
Dictyostelium discoideum: a model host to measure bacterial virulence | Q83162103 | ||
Clinical Diagnosis of Legionnaire's Disease: Six Characteristic Clinical Predictors | Q85410804 | ||
How academic labs can approach the drug discovery process as a way to synergize with big pharma | Q86889793 | ||
Deducing the mechanism of action of compounds identified in phenotypic screens by integrating their multiparametric profiles with a reference genetic screen | Q87202121 | ||
Intrinsic Antibacterial Activity of Nanoparticles Made of β-Cyclodextrins Potentiates Their Effect as Drug Nanocarriers against Tuberculosis | Q92043792 | ||
Structure of the gating ring from the human large-conductance Ca(2+)-gated K(+) channel | Q24602501 | ||
Subversion of Cell-Autonomous Immunity and Cell Migration by Legionella pneumophila Effectors | Q26781334 | ||
Structural Determinants of Phosphoinositide 3-Kinase Inhibition by Wortmannin, LY294002, Quercetin, Myricetin, and Staurosporine | Q27628650 | ||
The catalytic mechanism of indole-3-glycerol phosphate synthase: crystal structures of complexes of the enzyme from Sulfolobus solfataricus with substrate analogue, substrate, and product | Q27639134 | ||
Structural basis for the inhibition of Mycobacterium tuberculosis glutamine synthetase by novel ATP-competitive inhibitors | Q27657102 | ||
Design of O -Acetylserine Sulfhydrylase Inhibitors by Mimicking Nature | Q27658287 | ||
Structural basis for human monoglyceride lipase inhibition | Q27658438 | ||
Crystal structure of a soluble form of human monoglyceride lipase in complex with an inhibitor at 1.35 Å resolution | Q27666922 | ||
The crystal structure of a voltage-gated sodium channel | Q27670752 | ||
Methicillin-resistant Staphylococcus aureus (MRSA) Pyruvate Kinase as a Target for Bis-indole Alkaloids with Antibacterial Activities | Q27675245 | ||
Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings | Q27861111 | ||
Sulfo-N-succinimidyl esters of long chain fatty acids specifically inhibit fatty acid translocase (FAT/CD36)-mediated cellular fatty acid uptake | Q27887122 | ||
A knowledge-based approach in designing combinatorial or medicinal chemistry libraries for drug discovery. 1. A qualitative and quantitative characterization of known drug databases | Q28140411 | ||
Crystal structure of a mammalian voltage-dependent Shaker family K+ channel | Q28260421 | ||
Navigating chemical space for biology and medicine | Q28298611 | ||
Discovery of novel nitrobenzothiazole inhibitors for Mycobacterium tuberculosis ATP phosphoribosyl transferase (HisG) through virtual screening | Q28487571 | ||
Exploring anti-bacterial compounds against intracellular Legionella | Q28533449 | ||
Establishment and validation of whole-cell based fluorescence assays to identify anti-mycobacterial compounds using the Acanthamoeba castellanii-Mycobacterium marinum host-pathogen system | Q28539402 | ||
Novel inhibitors of cholesterol degradation in Mycobacterium tuberculosis reveal how the bacterium's metabolism is constrained by the intracellular environment | Q28543551 | ||
ZINC 15--Ligand Discovery for Everyone | Q28607096 | ||
Virtual screening: an in silico tool for interlacing the chemical universe with the proteome. | Q30366496 | ||
Rule of five in 2015 and beyond: Target and ligand structural limitations, ligand chemistry structure and drug discovery project decisions | Q30387813 | ||
Amoebae-resisting bacteria isolated from human nasal swabs by amoebal coculture | Q30925319 | ||
LINGO, an efficient holographic text based method to calculate biophysical properties and intermolecular similarities | Q30986370 | ||
ChemGPS-NP: tuned for navigation in biologically relevant chemical space | Q33282287 | ||
Scaffold composition and biological relevance of screening libraries. | Q33291102 | ||
ChemGPS-NP(Web): chemical space navigation online | Q33392980 | ||
Mycobacterium marinum antagonistically induces an autophagic response while repressing the autophagic flux in a TORC1- and ESX-1-dependent manner | Q33611027 | ||
Amoebae as training grounds for intracellular bacterial pathogens | Q33722169 | ||
In Silico Driven Design and Synthesis of Rhodanine Derivatives as Novel Antibacterials Targeting the Enoyl Reductase InhA. | Q40145483 | ||
Small molecule inhibitors of HDM2 ubiquitin ligase activity stabilize and activate p53 in cells | Q40410781 | ||
Testing chemical and genetic Modulators in Mycobacterium tuberculosis infected cells using phenotypic assays | Q41425604 | ||
Save Antibiotics: a call for action of the World Alliance Against Antibiotic Resistance (WAAAR). | Q42353812 | ||
A marine natural product inhibitor of kinesin motors. | Q43745151 | ||
Small molecule enhancers of rapamycin-induced TOR inhibition promote autophagy, reduce toxicity in Huntington's disease models and enhance killing of mycobacteria by macrophages | Q45306203 | ||
Impact of high-throughput screening in biomedical research | Q45352809 | ||
Three-dimensional structure-activity relationship study of belactosin A and its stereo- and regioisomers: development of potent proteasome inhibitors by a stereochemical diversity-oriented strategy. | Q45933219 | ||
A novel inhibitor of indole-3-glycerol phosphate synthase with activity against multidrug-resistant Mycobacterium tuberculosis | Q46229436 | ||
Flotillin and RacH modulate the intracellular immunity of Dictyostelium to Mycobacterium marinum infection | Q46473864 | ||
Eat Prey, Live: Dictyostelium discoideum As a Model for Cell-Autonomous Defenses. | Q47556585 | ||
Survey on medicinal plants traditionally used in Senegal for the treatment of tuberculosis (TB) and assessment of their antimycobacterial activity | Q47736263 | ||
Formation of the Legionella-containing vacuole: phosphoinositide conversion, GTPase modulation and ER dynamics. | Q47865277 | ||
Molecular characterization and identification of surrogate substrates for diacylglycerol lipase α. | Q49014747 | ||
When Dicty Met Myco, a (Not So) Romantic Story about One Amoeba and Its Intracellular Pathogen | Q49623828 | ||
Dictyostelium discoideum as a surrogate host-microbe model for antivirulence screening in Pseudomonas aeruginosa PAO1. | Q50219316 | ||
A Mycobacterium marinum TesA mutant defective for major cell wall-associated lipids is highly attenuated in Dictyostelium discoideum and zebrafish embryos | Q33837348 | ||
2,3-Substituted quinoxalin-6-amine analogs as antiproliferatives: a structure-activity relationship study | Q33837666 | ||
Eat, kill or die: when amoeba meets bacteria | Q34012225 | ||
Medicinal plants in therapy | Q34193129 | ||
NetWalker: a contextual network analysis tool for functional genomics | Q34316790 | ||
Molecular characterization of the evolution of phagosomes | Q34344310 | ||
Fueling open-source drug discovery: 177 small-molecule leads against tuberculosis | Q34544301 | ||
ABC multidrug transporters: structure, function and role in chemoresistance. | Q34586418 | ||
Small molecules enhance autophagy and reduce toxicity in Huntington's disease models. | Q34626231 | ||
Infection by tubercular mycobacteria is spread by nonlytic ejection from their amoeba hosts | Q34969920 | ||
Intracellular replication of Mycobacterium marinum within Dictyostelium discoideum: efficient replication in the absence of host coronin | Q35013023 | ||
A chemical genetic screen in Mycobacterium tuberculosis identifies carbon-source-dependent growth inhibitors devoid of in vivo efficacy | Q35561761 | ||
Progress and challenges in implementing HIV care and treatment policies in Latin America following the treatment 2.0 initiative | Q35873661 | ||
Dictyostelium as host model for pathogenesis | Q36023742 | ||
Amoebae-Based Screening Reveals a Novel Family of Compounds Restricting Intracellular Legionella pneumophila | Q36131365 | ||
High-throughput identification and rational design of synergistic small-molecule pairs for combating and bypassing antibiotic resistance | Q36410455 | ||
Environmental predators as models for bacterial pathogenesis. | Q36734988 | ||
Morphine induces ubiquitin-proteasome activity and glutamate transporter degradation | Q36798747 | ||
A quantitative model of intracellular growth of Legionella pneumophila in Acanthamoeba castellanii. | Q36954660 | ||
Novel inhibitors of the calcineurin/NFATc hub - alternatives to CsA and FK506? | Q37622487 | ||
Amoebae as a tool to isolate new bacterial species, to discover new virulence factors and to study the host-pathogen interactions | Q37843856 | ||
Enoyl acyl carrier protein reductase inhibitors: a patent review (2006 - 2010). | Q37886187 | ||
From amoeba to macrophages: exploring the molecular mechanisms of Legionella pneumophila infection in both hosts | Q38129263 | ||
Relevance of free-living amoebae as hosts for phylogenetically diverse microorganisms | Q38211766 | ||
Predicting natural product value, an exploration of anti-TB drug space. | Q38216493 | ||
Legionella pneumophila: homeward bound away from the phagosome | Q38280765 | ||
Formation of a pathogen vacuole according to Legionella pneumophila: how to kill one bird with many stones. | Q38436575 | ||
Adrenergic antagonists restrict replication of Legionella | Q38887229 | ||
A model to predict anti-tuberculosis activity: value proposition for marine microorganisms | Q38894536 | ||
Synthesis and biological evaluation of benzo[4,5]imidazo[1,2-c]pyrimidine and benzo[4,5]imidazo[1,2-a]pyrazine derivatives as anaplastic lymphoma kinase inhibitors | Q39030057 | ||
Dinitrophenol, Dicoumarol and Pentachlorophenol as Inhibitors and Parasite Substrates in the ATP Phosphoribosyltransferase Reaction | Q39394743 | ||
Legionella pneumophila utilizes the same genes to multiply within Acanthamoeba castellanii and human macrophages | Q39610405 | ||
Antimetastatic effect of a small-molecule vacuolar H+-ATPase inhibitor in in vitro and in vivo preclinical studies | Q40073510 | ||
The Legionella pneumophila response regulator LqsR promotes host cell interactions as an element of the virulence regulatory network controlled by RpoS and LetA. | Q40110647 | ||
Inhibitors of Mycobacterium marinum virulence identified in a Dictyostelium discoideum host model | Q40126421 | ||
Acanthamoeba and Dictyostelium as Cellular Models for Legionella Infection. | Q52350987 | ||
Antimycobacterial drug discovery using Mycobacteria-infected amoebae identifies anti-infectives and new molecular targets. | Q52676415 | ||
How To Optimize Shape-Based Virtual Screening: Choosing the Right Query and Including Chemical Information | Q53348684 | ||
A unified, probabilistic framework for structure- and ligand-based virtual screening. | Q53438912 | ||
Genome sequencing and functional characterization of the non-pathogenic Klebsiella pneumoniae KpGe bacteria. | Q54213669 | ||
Design, synthesis, and biological evaluation of fluorinated analogues of salicylihalamide. | Q54776757 | ||
High throughput evaluation of macrocyclization strategies for conformer stabilization. | Q55178656 | ||
Combined docking and molecular dynamics simulations to enlighten the capacity of Pseudomonas cepacia and Candida antarctica lipases to catalyze quercetin acetylation | Q56927779 | ||
Tuberculosis | Q57235679 | ||
Arylvinylpiperazine Amides, a New Class of Potent Inhibitors Targeting QcrB of Mycobacterium tuberculosis | Q57291166 | ||
In vitro Biological Characterization of a Novel, Synthetic Diaryl Pyrazole Resorcinol Class of Heat Shock Protein 90 Inhibitors | Q58001173 | ||
Pancreatic lipase inhibition activity of trilactone terpenes ofGinkgo biloba | Q59447017 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P4510 | describes a project that uses | ggplot2 | Q326489 |
RStudio | Q4798119 | ||
dplyr | Q104854189 | ||
P304 | page(s) | 266 | |
P577 | publication date | 2020-02-21 | |
P1433 | published in | Frontiers in Microbiology | Q27723481 |
P1476 | title | Identification of Anti-Mycobacterium and Anti-Legionella Compounds With Potential Distinctive Structural Scaffolds From an HD-PBL Using Phenotypic Screens in Amoebae Host Models | |
P478 | volume | 11 |